Palogic Value Management’s Health Catalyst HCAT Stock Holding History

Palogic Value Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.8M	Buy	4,922,442 +2,025,842	+70%	+$2.92M	3.23%	5
2026 Q1	$3.68M	Buy	2,896,600 +1,626,559	+128%	+$3.06M	1.55%	15
2025 Q4	$3.04M	Buy	1,270,041 +178,222	+16%	+$487K	1.27%	19
2025 Q3	$3.11M	Buy	1,091,819 +361,719	+50%	+$1.24M	1.25%	19
2025 Q2	$2.75M	Buy	730,100 +80,100	+12%	+$315K	1.12%	25
2025 Q1	$2.94M	Buy	650,000 +330,000	+103%	+$1.75M	1.27%	23
2024 Q4	$2.26M	Buy	+320,000	New	+$2.55M	0.86%	36

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Palogic Value Management's HCAT Position: Q2 2026 in Review

Palogic Value Management increased its Health Catalyst (HCAT) stake by 70% in Q2 2026, buying an estimated $2.92M and bringing the position to 4,922,442 shares worth $9.8M. The position accounts for 3.23% of the portfolio, ranked #5.

Palogic Value Management first reported a position in HCAT in Q4 2024 and has held it in 7 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Palogic Value Management held 4,922,442 shares of Health Catalyst worth $9.8M as of Q2 2026.
Palogic Value Management bought 2,025,842 Health Catalyst shares in Q2 2026, an estimated $2.92M.
Health Catalyst made up 3.23% of Palogic Value Management's portfolio in Q2 2026, its #5 holding.
Palogic Value Management first reported a position in Health Catalyst in Q4 2024 and has held it in 7 quarters since.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.